TG THERAPEUTICS, INC. Annual Net Income (Loss) Attributable to Parent in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Tg Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2023.
  • Tg Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was $6.88M.
  • Tg Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was $95.7M.
  • Tg Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was $12.7M.
  • Tg Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$198M, a 43% increase from 2021.
  • Tg Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$348M.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $12.7M +$211M Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 -$198M +$150M +43% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 -$348M Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2013 -$20.5M -$2.41M -13.3% Jan 1, 2013 Dec 31, 2013 10-K 2014-03-07
2012 -$18.1M -$17.2M -2019% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-07
2011 -$853K -$1.48M -237% Jan 1, 2011 Dec 31, 2011 10-K 2013-03-21
2010 $624K Jan 1, 2010 Dec 31, 2010 10-Q 2011-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.